Ralph Martins

Adjunct Professor

  • The University of Western Australia (M650), 35 Stirling Highway,

    6009 Perth

    Australia

  • 12345 Citations
  • 53 h-Index
1992 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile

Keywords

  • Cholesterol metabolism and Alzheimer's disease
  • Drug development
  • Exercise and prevention of Alzheimer's disease
  • Genetics of Alzheimer's disease
  • Gonadotropins
  • Insulin resistance and Alzheimer's disease
  • Interaction between sex hormones and apoliprotein E
  • Mechanism(s) of apolipoprotein E action
  • Memory and ageing
  • Memory and Alzheimer's disease
  • Molecular biology of Alzheimer's disease
  • Neuroscience: Alzheimer's disease

Fingerprint Dive into the research topics where Ralph Martins is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Alzheimer Disease Medicine & Life Sciences
Amyloid Medicine & Life Sciences
Apolipoproteins E Medicine & Life Sciences
Brain Medicine & Life Sciences
Cognition Medicine & Life Sciences
Apolipoprotein E4 Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Amyloid beta-Protein Precursor Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease

Ashton, N. J., Nevado-Holgado, A. J., Barber, I. S., Lynham, S., Gupta, V., Chatterjee, P., Goozee, K., Hone, E., Pedrini, S., Blennow, K., Schöll, M., Zetterberg, H., Ellis, K. A., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D., Masters, C. L., Aarsland, D., Powell, J. & 3 othersLovestone, S., Martins, R. & Hye, A., 6 Feb 2019, In : Science Advances. 5, 2, eaau7220.

Research output: Contribution to journalArticle

Open Access
classifiers
Amyloid
Proteomics
Blood Proteins
Alzheimer Disease
2 Citations (Scopus)

Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer's disease: Are combinations more effective?

Sharman, M. J., Gyengesi, E., Liang, H., Chatterjee, P., Karl, T., Li, Q. X., Wenk, M. R., Halliwell, B., Martins, R. N. & Münch, G., 1 Apr 2019, In : Neurobiology of Disease. 124, p. 505-519 15 p.

Research output: Contribution to journalArticle

Thioctic Acid
Curcumin
Docosahexaenoic Acids
Amyloid
Transgenic Mice
1 Citation (Scopus)

Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis

Dhiman, K., Blennow, K., Zetterberg, H., Martins, R. N. & Gupta, V. B., 30 May 2019, In : Cellular and Molecular Life Sciences. 76, 10, p. 1833-1863 31 p.

Research output: Contribution to journalReview article

Cerebrospinal Fluid
Alzheimer Disease
Biomarkers
Brain Diseases
Pathology

Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau

Jacobs, K. R., Lim, C. K., Blennow, K., Zetterberg, H., Chatterjee, P., Martins, R. N., Brew, B. J., Guillemin, G. J. & Lovejoy, D. B., 1 Aug 2019, In : Neurobiology of Aging. 80, p. 11-20 10 p.

Research output: Contribution to journalArticle

Kynurenine
Amyloid
Cerebrospinal Fluid
Alzheimer Disease
Neopterin

Subjective memory complaints predict baseline but not future cognitive function over three years: Results from the Western Australia Memory Study

Sohrabi, H. R., Weinborn, M., Laske, C., Bates, K. A., Christensen, D., Taddei, K., Rainey-Smith, S. R., Brown, B. M., Gardener, S. L., Laws, S. M., Martins, G., Burnham, S. C., Bucks, R. S., Reisberg, B., Lautenschlager, N. T., Foster, J. & Martins, R. N., Apr 2019, In : International Psychogeriatrics. 31, 4, p. 513-525 13 p.

Research output: Contribution to journalArticle

Western Australia
Cognition
Dementia
Independent Living

Projects 1996 2017